Results 141 to 150 of about 5,590,035 (204)

Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysis. [PDF]

Front Transplant
Yaseen A, Mubaydeen T, Al-Qaraleh H, Otoom A, Shaban S, Mesmar H, Alomoush A, Da'Na W, Halahleh K, Abu Jazar H, Saadeh S, Ma'koseh M, Shamieh A, Kullab S, Abu Ata O, Jarrah J, Abdel Rahman Z.   +16 more
europepmc   +1 more source

Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis. [PDF]

Ann Hematol
Angleitner AC, Maulhardt M, Treiber H, Hasenkamp J, Büntzel J, Wulf GG.   +5 more
europepmc   +1 more source

Neighborhood Social Vulnerability and Cardiovascular Risk After Allogeneic Hematopoietic Cell Transplantation. [PDF]

JACC Adv
Bhandari R, Ogiamien O, Chen S, Al Malki M, Artz AS, Bosworth A, Echevarria M, Rhee JW, Wong FL, Armenian SH.   +9 more
europepmc   +1 more source

Long-term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma. [PDF]

In Vivo
Hur JY, Park HS, Choi Y, Park H, Lee YE, Jeong J, Cha S, Choi EJ, Lee JH, Lee YS, Jeon M, Woo JM, Kang YA, Kang H, Lee JH.   +14 more
europepmc   +1 more source

Significance of CD34⁺ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD Status. [PDF]

Transplant Cell Ther
Gang M, Othus M, Olix AC, Kaur G, Yakub F, Davis C, Basom RS, Markey KA, Stirewalt DL, Connelly-Smith LS, Milano F, Walter RB.   +11 more
europepmc   +1 more source

Low-positive CMV IgG serostatus before allogeneic hematopoietic cell transplantation is not associated with increased CMV reactivation risk. [PDF]

Bone Marrow Transplant
Nägele K, Walti C, Gosert R, Schmidhauser MK, Bargetzi A, Mills D, Passweg J, Halter J, Matteazzi F, Baettig V, Bloemberg GV, Khanna N, Leuzinger K.   +12 more
europepmc   +1 more source

It Mite Not Be Graft-Versus-Host Disease: Frequency and Clinical Features of Demodex Folliculitis After Allogeneic Hematopoietic Cell Transplantation. [PDF]

Transplant Cell Ther
Xue E, Cusmano A, Hyder MA, Dimitrova D, Sabina R, Rechache K, Allbritton J, Huang E, Brownell I, Castelo-Soccio L, Nagao K, Kong HH, Karacki K, Cousineau-Krieger C, Magone MT, Cowen EW, Kanakry JA, Kanakry CG.   +17 more
europepmc   +1 more source

Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation. [PDF]

Blood Adv
Holtan SG, Grover P, Walton K, El Jurdi N, Quinones V, Maakaron JE, Juckett MB, Bachanova V, Hou JH, Terezakis S, Myers TJ, Paradiso LJ, DeFor TE, Cao Q, Betts BC.   +14 more
europepmc   +1 more source

Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility. [PDF]

Transpl Infect Dis
Rodriguez-Rodriguez S, Sayyed A, Linn SM, Chiarello C, Remberger M, Novitzky-Basso I, Rogalla P, Husain S, Mattsson J.   +8 more
europepmc   +1 more source